The Italy peptide receptor radionuclide therapy (PRRT) market offers significant potential for growth due to the increasing prevalence of various types of cancer in the country. PRRT involves the use of radiolabeled peptides that bind to receptors on cancer cells and deliver radiation therapy internally. The targeted delivery of therapeutic radioisotopes allows for highly effective treatment of neuroendocrine tumors and other cancers. PRRT has emerged as an effective alternative or addition ... Read more
